|
|
Our laboratories are involved in the improvement of currently available tests used for the screening, early detection, and monitoring of Renal Disease |
 |
Research Scientist, Ioana Niculescu-Duvaz, working in conjunction with Dr Jeff Barron’s Clinical Chemistry Department at St Helier Hospital, is developing a new method for measuring glomerular filtration rate. This new method is considerably less invasive and more patient friendly than previous approaches.
As an interesting addition to this, Ioana is also studying the production of the important scar protein, fibronectin, by human renal tubule cells to investigate whether this might be a target for future therapy in the treatment of kidney fibrosis. |
| |
 |
Junior Research Fellow, Sarah Yates, working in conjunction with Dr Marta Lapsley, Honorary Senior Research Fellow, is involved in a new study into undetected kidney disease in the community - the London Lifescience Population (LOLIPOP) study. In this study the blood and urine of cardiac patients in the Indo-Asian and European White populations are being screened for markers of early stage renal disease. These markers are raised levels of elements that would normally be absent in the blood and urine. It is hoped that as many as 10,000 members of these populations will be screened. |
|
|
